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Abstract 
Study design: International expert working group. 
Objective: To revise the International Spinal Cord Injury (SCI) Bowel Function 
Basic Data Set as a standardized format for the collecting and reporting of a minimal 
amount of information on bowel function in clinical practice and research. 
Setting:Working group appointed by the American Spinal injury association (ASIA) 
and the International Spinal Cord Society (ISCoS). 
Methods: The draft prepared by the working group was reviewed by the International 
SCI Data Set Committee and later by members of the ISCoS Executive and Scientific 
Committees and the ASIA board. The revised data set was posted on the ASIA and 
ISCoS websides for one month to allow further comments and suggestions. Changes 
resulting from a Delphi process among experts in children SCI were included. 
Members of ISCoS Executive and Scientific Committees, and the ASIA board made a 
final review and approved the data set. 
Results: The International SCI Bowel Function Basic Data Set (Version 2.0) consists  
of 16 items: date of data collection, gastrointestinal and anal sphincter dysfunction 
unrelated to SCI, surgical procedures on the gastrointestinal tract, defecation method 
and bowel care procedures, average time required for defecation, frequency of 
defecation, uneasiness, headache or perspiration during defecation, digital stimulation 
or evacuation of the anorectum, frequency of fecal incontinence, flatus incontinence, 
need to wear pad or plug, oral laxatives and prokinetics, anti-diarrhoeal agents, 
perianal problems, abdominal pain and dyscomfort, and the neurogenic bowel 
dysfunction score. 
Conclusion: The International SCI Bowel Function Basic Data Set (Version 2.0) has  
been developed. 
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Introduction 
Spinal cord injury (SCI) has serious consequences for bowel function.1-3 The majority 
of individuals with SCI suffer from neurogenic bowel dysfunction (NBD) including 
constipation, fecal incontinence or abdominal pain. Thus, 42-95% of individuals with 
SCI report constipation,1-5 65% need digital stimulation or evacuation of the 
anorectum,2 25-41% need more than 30 minutes for bowel emptying,2,5 75% have 
episodes of fecal incontinence,2 including 20-33% who are incontinent at least once 
per month,2,5 and 34-38 % have chronic abdominal pain.5,6 The severity of NBD 
depends on the completeness of SCI 2 and both prevalence and severity tend to 
increase with time after injury.6,7 
 The International SCI Bowel Function Basic Data Set (Version 1.0) was 
constructed and published in 2009 as a standardized format for the collection and 
reporting of a minimal amount of information on bowel function in daily practice.8 
After several comments were received by the authors and the ISCoS Data Set 
Committee, the data set underwent minor revision later the same year, however, 
without changing its basic structure. In line with the aim of the International SCI Data 
Sets,9 an International SCI Bowel Function Extended Data Set was developed to 
guide the collection of clinically relevant data in scientific studies on NBD.10 Today, 
the International SCI Bowel Function Basic Data Set has been used in several studies 
and it is included in databases around the world.  
 The inter-rater reliability of the International SCI Bowel Function Basic 
and Extended Data Sets was tested in an international setting in 2012.11 Most 
variables had acceptable reliability and only minor adjustments were recommended. 
A basic feature with the construction of the International SCI Bowel Function Data 
Sets was that by combining the basic and extended data sets, two commonly used 
scores for constipation and fecal incontinence could be computed.12,13 The two scores 
have, however, not been validated among individuals with SCI. Furthermore, the 
option of computing them has not been used in international publications on 
individuals with SCI in the years following its publication.  
 The NBD score was developed in 2006 as a simple validated score to 
assess bowel dysfunction in adult individuals with SCI.14 The score includes 10 items 
which are associated with impaired quality of life caused by bowel symptoms. Each 
item is weighted according to the strength of its association with self-reported 
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impaired quality of life. The NBD score has been used in several trials and other 
publications and it has been translated into at least nine languages. Most of the 
variables from the NBD score were already included in the International SCI Bowel 
Function Basic Data Set (Version 1.0 and 1.1). It is, however, impractical to have two 
very similar parallel tools for description of NBD. Thus, the current version of the 
data set allows easy computation and interpretation of the NBD score.  
 The International SCI Bowel Function Basic Data Set was developed for 
adults with SCI and it has not been tested specifically among children. There is, 
however, also a need for standardized collection and reporting of data on bowel 
function in children with SCI. It is proposed to use the present data set among 
children aged more than 3-4 years where bowel continence is expected. This has 
necissitated some clarifying comments in to some variables in syllabus for the data 
set. In general, when used with children, parents or primary caregivers are the primary 
sources for report until approximately 11 years of age. At the age 12-15, parent and 
child report in combination is proposed. The validity of the NBD score was tested in 
adults and neither the score nor its interpretation is directly applicable to children.  
 The aims of the present work were to revise the International SCI Bowel 
Function Basic Data Set (Version 1.1) based on experiences with its use since 
publication, to include the NBD score in the revised version, and to modify the 
syllabus for the data set in order to allow its use among children with SCI.    
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Methods 
The development of the International SCI Bowel Function Basic Data Set (Version 
2.0) was very similar to the construction of its first version and to the development of 
other International SCI data sets.9 A working group was formed, including members 
appointed by the American Spinal Injury Association (ASIA) and the International 
Spinal Cord Society (ISCoS) and a representative from the of the International SCI 
Data Set Committee. A literature search was made on PubMed and Scopus to identify 
publications referring to the International SCI Bowel Function Basic Data Set and the 
NBD score. Practical experiences and results from the reliability study were also 
considered.11 The developmental process for the data set followed the steps below: 
 
1) The chairman of the working group (KK) wrote a draft for the data set and a 
syllabus both of which were circulated among the members of the group for 
comments. Based on their comments a second draft was made. 
2) The data set was reviewed by members of the International SCI Data Set 
Committee.   
3) Comments from the committee members were sent to the working group and 
relevant changes were made. 
4) Members of the ISCoS Executive and Scientific Committees and the ASIA board 
were invited to comment the data set. 
5) The working group prepared a response to comments from the Committees/Board 
members and further changes were made in the data set. 
6) Relevant societies, organisations and individuals with a potential interest were 
invited to comment and the data set was posted on the ISCoS and ASIA websites for 
one month open to comments and suggestions. 
7) Minor adjustments were made after discussion in the working group.  
8) The results obtained from a Delphi process among experts in children SCI were 
included.  
9) Members of ISCoS Executive and Scientific Committees, and ASIA board received 
the data set for final review and approval. 
10) Endorsement by relevant international organizations and societies will be sought.  
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Results 
 
The data set form is shown in the appendix. The complete data sheet, data syllabus is 
available on the website of ISCoS (www.iscos.org.uk/international-sci-bowel-data-
sets). 
In the previous version of the data set, the time period listed for various symptoms 
varied. This is now four weeks for all. 
 
Date of data collection  
As the collection of data on bowel function may be carried out at any time since SCI, 
the date of data collection is imperative to compute time since injury and to identify 
the data collected in relation to other data collected on the same individual at various 
time points.  
This variable is unchanged from the previous version of the data set. 
 
Gastrointestinal or anal sphincter dysfunction unrelated to SCI 
This relates to gastrointestinal or anal sphincter dysfunction concomitant and thus 
unrelated to changes in bowel function due to SCI. Functional gastrointestinal 
disorders, especially irritable bowel syndrome and idiopathic constipation, are very 
common in the general population. The prevalence depends on the exact definitions 
used but varies from 5% up to approximately 20%. The presence of functional or 
other gastrointestinal disorders before SCI may affect symptoms and treatment 
outcome.  
Anal sphincter lesions due to childbirth are common and may contribute to fecal  
incontinence.15 Many types of gastrointestinal and anal sphincter dysfunction exist  
and it is therefore impractical to give an exact list of such conditions. 
This variable is unchanged from the previous version of the data set. 
 
Surgical procedures on the gastrointestinal tract 
For the overall assessment of bowel function in individuals with SCI, information 
about surgical procedures on the gastrointestinal tract is important. This variable 
covers any surgical procedure on the gastrointestinal tract before or after SCI. It also 
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includes perianal surgery. Due to the large number of possible surgical procedures, it 
is impractical to list more than the most important or common.  
This variable is unchanged from the previous version of the data set. 
 
 
Defecation method and bowel care procedures  
Individuals with SCI may use a combination of bowel emptying procedures. For 
practical purposes one should be defined as the Main method. This is the method 
considered most important by the individual and the doctor or nurse. To be included 
in the dataset, supplementary methods should be performed at least once every week.  
More than one supplementary method can be used. The choice of defecation method 
and bowel care procedures may change with time and in the present data set they are 
given for the last four weeks. “Digital ano-rectal stimulation” indicates use of a finger 
to trigger rectal contractions and anal relaxation, inducing rectal emptying. “Digital 
evacuation”, by contrast, is the need to dig out stools with a finger. Mini enema (or 
Clysma) contains 150 mL or less, and enema contain >150 mL. In individuals having 
a colostomy, this is always considered the main method for defecation. This variable 
is unchanged from the previous version of the data set. Not applicable is primary for 
children who are not of age for bowel continence.  
 
Average time required for defecation  
Time needed for defecation is clinically very important and strongly associated with 
impact on quality of life.2 The time given is from first transferring to the toilet or 
commode until end of defecation and transferal to wheel chair or moving from the 
toilet. If bladder emptying, body washing, shaving etc. is also performed while sitting 
at the toilet time for this is subtracted as far as possible. For individuals performing 
bowel management while lying in the bed, time required is from beginning to end of 
bowel management, not including time for bladder management, body washing etc. 
Time needed for defecation is the assessed average time for each defecation within 
the last four weeks. This variable does not distinguish between spontaneous or 
assisted defecation.  
The number of possible answers within this variable has been reduced from seven to 
four. This in accordance with the NBD score and makes the variable simpler to use. 
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Frequency of defecation  
The frequency of defecation is very variable. However, in the general population 
more than 94% defecate between three times per day and three times per week.16 
Among individuals with SCI approximately 3% defecate less than once every week.2 
Infrequent defecation is an indicator of insufficient bowel management and associated 
with impact on quality of life. 
The number of possible answers within this variable has been reduced from ten to 
five. This in accordance with the NBD score and makes the item simpler to use. 
 
Uneasiness, headache or perspiration during defecation  
The feelings of general uneasiness and headache and the presence of perspiration 
during defecation is reported by approximately 25% of individuals with SCI.2,5  
The symptoms are mainly present in individuals with cervical or upper thoracic 
lesions and indicate that autonomic dysreflexia occurs during defecation. Digital 
anorectal stimulation, rectal evacuation or transanal irrigation may cause autonomic 
dysreflexia either with symptoms or as silent autonomic dysreflexia.17 For children, 
fussiness and irritability are common signs that autonomic dysreflexia may be 
present.18 This variable is new in the data set but part of the NBD score. 
 
Digital stimulation or evacuation of the anorectum  
Digital stimulation or evacuation is reported by approximately two thirds of 
individuals with SCI.2 In some, it indicates poor emptying of the rectum and the use 
of digitation is associated with impaired quality of life due to NBD.  
The variable is part of the NBD score and now also included in the data set. 
 
Frequency of fecal incontinence 
Fecal incontinence is defined as involuntary passage of stools. It has profound 
influence on quality of life and may cause severe restriction on social activities. This 
variable does not distinguish between incontinence to solid or liquid stools but does 
exclude flatus incontinence. In individuals with ileo- or colostomy leakage is 
considered as fecal incontinence. The number of possible answers within this variable 
has been reduced from eight to five. This in accordance with the NBD score and 
makes the variable simpler to use. The variable is not applicable for children who are 
not of age for bowel continence. 
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Flatus incontinence 
Flatus incontinence is defined as involuntary passage of gas. In individuals with ileo- 
or colostomy leakage of gas from the stoma bag is considered as flatus incontinence. 
This variable is part of the NBD score and now also included in the data set. 
 
Need to wear pad or plug 
This variable describes the need to wear a pad due to fecal incontinence or combined 
fecal and urinary incontinence. The need to wear a pad only for urinary incontinence 
is not included. The need to wear a pad indicates insufficient bowel management. The 
use of anal plug is mainly relevant for individuals with conal or cauda equina lesions. 
To make the variable easy to use, the number of possible answers has been reduced to 
Yes/No. 
 
Oral laxatives and prokinetics 
Oral laxatives are commonly used by individuals with SCI. A large number of oral 
laxatives exist either as liquids/drops or tablets/capsules/granulates and it is 
impractical to give a full list within the frames of this data set. Commonly used 
bulking or osmotic agents are lactulose, psyllium, magnesium and sorbitol.  
Commonly used irritant laxatives are bisacodyl and sodium picosulphate.  
Use of the prokinetic drug: Prucalopride which was tested in a pilot study among 
individuals with SCI should be listed here.19 The guanylate cyclase-C receptor agonist 
Linaclotide and the chloride channel activator Lubiprostone have not yet been 
evaluated in individuals with SCI, but if used, they should also be listed here. 
The variable has been slightly modified to include new drugs and it is also part of the 
NBD score. If both liquids/drops and tablets are used the number of points given in 
the NBD score will be four. 
 
Anti-diarrhoeal agents 
Fibre supplement and constipating drugs are usually first line therapy against fecal  
incontinence of non-neurogenic origin. The most commonly used drug is Loperamide.  
In individuals with SCI this approach is, however, rarely used as it may aggravate 
constipation. The variable only covers drugs taken with the aim of prolonging 
intestinal transit and to prevent fecal incontinence. Thus, the use of drugs which have 
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constipation as side effect, e.a. opioids or antocholinergics is not included. 
The variable has been simplified because medication affecting bowel function will 
usually be included in the (electronic) list of medication. This item is part of the NBD 
score. 
  
Perianal problems 
Due to straining and assisted defecation haemorrhoids, fissures, and rectal prolapse 
are more common among individuals with SCI than in the general population. Anal 
soiling may contribute to perianal sores. In the present data set, perianal sores are 
located within the crena ani or the perineum and not on the buttocks or lower back.  
For practical purposes, no distinction is made in the present data set between rectal 
mucosal prolapse and full-wall rectal prolapse. Perianal problems may change with 
time and only those present within the last four weeks should be noted. 
This variable is unchanged from the previous version of the data set, and is partly 
included in the NBD score. 
 
Abdominal pain and discomfort 
Abdominal pain is commonly reported by individuals with SCI and to many it causes 
serious discomfort.6,7 It may be a symptom of constipation. 
This variable is new in the data set. 
 
Total NBD score (optional) 
The NBD score has been developed and validated for assessment of bowel 
dysfunction in individuals with SCI.14 It is computed by adding the points given in 
parenthesis after each relevant variable in the data set. Interpretation of the score is 
shown to make the combined use of the NBD score and the data set easier (see 
Appendix). 
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Discussion 
The data within the International SCI Bowel Function Basic Data Set (Version 2.0) 
will usually be used in conjunction with data included in the International SCI Core 
Data Set and sometimes with data from other data sets.20 A significant change from 
the earlier version of the data set is, that it combines data needed for basic description 
of bowel function with those necessary to compute the NBD score. Thereby, a 
validated score for bowel dysfunction is directly available from the data set. This 
provides clinicians and researchers with a simple, validated and widely used tool for 
evaluation and monitoring of bowel function.  
 
The option of computing the Cleveland constipation score and a fecal incontinence 
score from items within the combined International SCI Bowel Function Basic and 
Extended Data Sets has been abandoned.12,13 The two scores are commonly used in 
able bodied, but they have not been validated in individuals with SCI. The authors 
considered including the Bristol stool scale in the data set, but decided not to do so 
because it has not been validated in individuals with SCI.21 Inclusion of the NBD 
score directly in the data set necessitated the inclusion of extra items while others 
could be simplified and the time range for symptoms reported could be standardized 
to four weeks.  
  
The international inter-rater reliability test of the International SCI Bowel Function 
Basic and Extended Data Sets identified problems with only few items.11 In the 
International SCI Bowel Function Basic Data Set the reporting of “mini enema” as a 
supplementary method within the item “Defecation method and bowel care 
procedures” had a kappa value of 0.19 (poor) and the option “other” within  
“Medication affecting bowel function/constipating agents” had a kappa value of 0.15  
(poor). For all remaining items in the present data set the inter-rater reliability was 
fair, moderate, good or very good.11 The reporting of specific medication affecting 
bowel function is no longer part of the data set as it is considered part of patients’ 
medication files. The same holds true for assessment of voluntary anal sphincter 
function which is part of the international standards to document remaining 
autonomic function after SCI.22 Another problem identified with both the basic and 
extended data sets was that some raters choose more than one response where only 
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one was allowed.11 We expect that this problem will be reduced because the number 
of possible answers has been reduced in several of the variables. 
The inter-rater reliability study further revealed that most raters rarely used the 
instructions for use for the data sets as posted in the ISCoS website.11 This is probably 
quite understandable in busy clinical practice and underlines the importance of data 
set forms being as self-explanatory as possible.    
 
Previous versions of the International SCI Bowel Function Basic and Extended Data 
Sets were developed for use in adult patients. Hence, there has been an unfulfilled 
need for an instrument to document neurogenic bowel symptoms in children. Data 
needed to develop such an instrument are not available, but based on expert opinion 
by a group af pediatricians with special experience within the field, it was decided to 
use the present version with a few extra explanatory remarks. Whether this is valid or 
not needs to be investigated in future studies. The NBD score was specifically 
developed and validated among adult patients with SCI and it is not directly 
applicable to children.  
 
 Most of the existing International SCI Data Sets are intended to be filled in by a 
healthcare professional and not developed for direct use by individuals with SCI.  
Development of patient-completed questionnaires as produced for the pain data set 
may further promote the use of the data sets.23 Such patient reported outcome 
measures could be developed for electronical use and filled in by the patient through 
email or an application for their telephone.  
 
Abdominal pain is common among subjects with SCI (6) but not included in the NBD 
score. When evaluation the severity of bowel symptoms in SCI iIt is often relevant to 
supplement the information from the NBD score with the subjective assessment of 
pain. Abdominal is sometimes, but not always, related to constipation (6). 
 
 
The International SCI Bowel Function Basic Data Set has been used in several studies 
and it is included in databases around the world. Therefore, changing the data set will 
have practical consequences for several people. We do, however, find that 
experiences made during the six years since the publication of the International SCI 
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Bowel Function Basic Data Set (Version 1.0) support the major revisions made in the 
present version. A measure of the success of these revisions will hopefully be reflexed 
in their increasing clinical and research use. Developing the data set is an ongoing 
process and all interested parties are encouraged to contact members of the working 
group or the ISCoS International SCI Data Set Committee through the first or last 
authors of this article. 
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Appendix 
 
INTERNATIONAL SPINAL CORD INJURY  
BOWEL FUNCTION BASIC DATA SET (Version 2.0) 
 
DATA COLLECTION FORM 
 
 
Date performed:   YYYYMMDD        Unknown  
 
Gastrointestinal or anal sphincter dysfunction unrelated to the spinal 
cord lesion: 
 No            Yes, specify______________________  Unknown 
 
Surgical procedures on the gastrointestinal tract: 
 No      Appendicectomy, date performed YYYYMMDD    
 Cholecystectomy, date performed YYYYMMDD  
 Colostomy, date last performed YYYYMMDD  
 Ileostomy, date last performed YYYYMMDD  
 Other, specify: ____________________, date last performed 
YYYYMMDD 
 Unknown 
 
 
Defecation method and bowel care procedures (within the last four 
weeks): 
Main      
Supplementary 
Normal defecation      
Straining / bearing down to empty     
Digital ano-rectal stimulation     
Suppositories       
Digital evacuation      
Mini enema (Clysma < 150 mL)     
Enema (> 150 mL)      
Colostomy       
Sacral anterior root stimulation     
Other method, specify______________________   
 Unknown 
 
 
Average time required for defecation (within the last four weeks):*  
 0-30 minutes (0)     31-60 minutes (3)      
 More than one hour (7)     
 Unknown 
 
Frequency of defecation (within the last four weeks):* 
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 Daily (0)     2-6 times per week (1)  
 Once every week or less (6)      
 Unknown 
Not applicable 
 
Uneasiness, headache or perspiration during defecation (within the last 
four weeks):* 
 No (0)            Yes (2) 
 Unknown 
 
Digital stimulation or evacuation of the anorectum (within the last four 
weeks):* 
 Daily (6)    Once or more per week (6)           Less than once per week (0) 
 Never (0) 
 Unknown 
 
Frequency of fecal incontinence (within the last four weeks):* 
 Daily (13)     1-6 times per week (7)      
 1-4 times every month (6)  
 Less than once per month (0)            Never (0) 
 Unknown 
 
Flatus incontinence (within the last four weeks):* 
 No (0)           Yes (2) 
 Unknown 
 
Need to wear diaper, pad or plug (within the last four weeks): 
 No            Yes 
 Unknown 
 
Oral laxatives (within the last four weeks):*   
 No (0)  Yes, drops or liquids (2)  
  Bulking/smotic    rritant 
  Yes, tablets, capsules or granulates (2) 
  Bulking/smotic    rritant 
   Prokinetics 
   Other, specify:_____________________ 
 Unknown 
 
Constipating agents/ drugs against fecal incontinence (within the last 
four weeks):* 
 No (0)            Yes (4) 
 Unknown 
 
Perianal problems (within the last four weeks):* 
 No (0)       Yes (3) 
   Haemorrhoids       Perianal sores      Fissures            
   Other, specify______________       Unknown 
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Abdominal pain or discomfort (within the last four weeks): 
 Daily    1-6 times per week       
 Once per week or less            Never 
 Unknown 
 
Total NBD Score (optional):*     
 0-6                  Very minor 
 7-9                  Minor 
          Moderate 
or more      Severe neurogenic bowel dysfunction 
 
* Items used for computation of the NBD score.  
 
Use of either drops/ liquids or tablets/ capsules/granulates each contribute 
with 2 points to the score.  
 
The NBD score has been validated in adults with spinal cord injury but not in 
children. 
    
  
